COMMUNIQUÉS West-GlobeNewswire

Medibio Receives TGA Approval
19/06/2018
SYDNEY, Australia and MINNEAPOLIS, June 19, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company )(ASX:MEB)(OTCQB:MDBIF), a mental health technology company, announced today it has received confirmation that [...]
Sanofi appoints Jean-Baptiste Chasseloup de Chatillon Executive Vice President, Chief Financial Officer
19/06/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi appoints Jean-Baptiste Chasseloup de Chatillon Executive Vice President, Chief Financial Officer Paris - June 19, 2018 - Sanofi has appointed Jean-Baptiste [...]
Sanofi nomme Jean-Baptiste Chasseloup de Chatillon au poste de Vice-Président Exécutif, Directeur financier
19/06/2018
Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) Sanofi nomme Jean-Baptiste Chasseloup de Chatillon au poste de Vice-Président Exécutif, Directeur financier Paris - Le 19 juin 2018 - Sanofi vient de [...]
Esperite N.V. secures external financing of up to EUR 5 million to support its commercial activity and development of innovative technologies
19/06/2018
Total investment can reach EUR 7.25 million upon exercise of share subscription warrants Amsterdam, The Netherlands - 19 June 2018 Transaction highlights Potential financing of up to EUR 5 million through private [...]
Sanofi : Sanofi completes its acquisition of Ablynx following the expiration of the Squeeze-out Procedure
19/06/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi completes its acquisition of Ablynx following the expiration of the Squeeze-out Procedure Paris, France and Ghent, Belgium - June 19, 2018 - Sanofi ( [...]
Sanofi : Sanofi finalise l'acquisition d'Ablynx à la suite de l'expiration de la procédure d'offre de reprise
19/06/2018
Communiqué de presse Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi finalise l'acquisition d'Ablynx à la suite de l'expiration de la procédure d'offre de reprise Paris, France et Gand, Belgique - Le 19 juin 2018 - [...]
SANOFI COMPLETES ITS ACQUITISION OF ABLYNX FOLLOWING THE EXPIRATION OF THE SQUEEZE-OUT PROCEDURE
19/06/2018
PARIS, France and GHENT, Belgium - June 19, 2018 - Sanofi (Euronext: SAN; NYSE: SNY) and Ablynx announced today that Sanofi has now acquired all outstanding shares (including shares represented by American Depositary [...]
CH Biotech Announces Grand Opening of Global R&D Innovation Center and Corporate Headquarters
19/06/2018
New Facility Is Taiwan's First International R&D Center Focused on Integrating Plant Health Systems NANTOU CITY, Taiwan, June 18, 2018 (GLOBE NEWSWIRE) -- CH Biotech R&D Co., Ltd. ("CH Biotech"), a leader in [...]
REVA Extends Technological Lead in Bioresorbable Scaffolds With CE Mark Approval of the Full Fantom® Encore Product Line
19/06/2018
SAN DIEGO, June 18, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, today announced it has received CE Mark [...]
BioStem Technologies Inc. Announces Issuance of Drug Enforcement Administration Registration for Qualified Pharma Ingredients
18/06/2018
Pompano Beach, FL, June 18, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a concentration [...]
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
18/06/2018
BOSTON, June 18, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic [...]
Sol-Gel Technologies Initiates Pivotal Phase III Clinical Program for Papulopustular Rosacea
18/06/2018
First subject dosed in pivotal Phase III program evaluating Epsolay ® in subjects with papulopustular rosacea Two Phase III trials expected to enroll a total of 700 subjects Top-line data expected to be reported in 2019 [...]
ObsEva Announces Launch of Proposed Follow-on Public Offering
18/06/2018
Geneva, Switzerland and Boston, MA - June 18, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]
Olainfarm Sales In The First Five Months Increase by 2%
18/06/2018
Olaine, June 18, 2018 Olainfarm Sales In The First Five Months Increase by 2% Consolidated Results May and 5 months of 2018 Preliminary consolidated Olainfarm Group sales in May 2018 were 8,67 million euros, which [...]
Biogen Foundation Selects Grantees to Receive $10 Million Investment for STEM Education
18/06/2018
CAMBRIDGE, Mass., June 18, 2018 (GLOBE NEWSWIRE) -- The Biogen Foundation today announced the six nonprofits that will share a previously-announced four-year, $10 million grant to drive the development of local STEM ( [...]
Bradmer Pharmaceuticals, Galaxy Digital and First Coin Announce Update
18/06/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES. TORONTO, June 18, 2018 (GLOBE NEWSWIRE) -- Bradmer Pharmaceuticals Inc. (“Bradmer” or the “Company”) (TSX VENTURE:BMR.H), Galaxy [...]
The Ensign Group Declares Quarterly Dividend of $0.045 Per Share
18/06/2018
MISSION VIEJO, Calif., June 18, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ:ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health, home care, hospice [...]
K2M Group Holdings, Inc. to Participate in JMP Securities 2018 Life Science Conference
18/06/2018
LEESBURG, Va., June 18, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional [...]
ESPERITE (ESP) further delays publication of Annual Report 2017.
18/06/2018
Amsterdam, The Netherlands - 18 June 2018 Esperite regrets to announce that due remaining technical issues as reported before and despite the constant efforts provided by the different teams involved, additional time is [...]

Pages